Advanced Cell Diagnostics Revenue and Competitors

Location

$40.8M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Advanced Cell Diagnostics's estimated annual revenue is currently $36.4M per year.(i)
  • Advanced Cell Diagnostics received $22.0M in venture funding in June 2015.
  • Advanced Cell Diagnostics's estimated revenue per employee is $193,750
  • Advanced Cell Diagnostics's total funding is $40.8M.

Employee Data

  • Advanced Cell Diagnostics has 188 Employees.(i)
  • Advanced Cell Diagnostics grew their employee count by -4% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$1.1M70%N/AN/A
#4
$2.3M15150%N/AN/A
#5
$1.4M90%N/AN/A
#6
$11.5M74-12%N/AN/A
#7
$0.4M27510%$236.7MN/A
#8
$4M51-74%$160MN/A
#9
$2.5M1633%N/AN/A
#10
$3.3M21-12%N/AN/A
Add Company

ACD - a Bio-Techne brand, (www.acdbio.com) shortens the path to personalized medicine and enables research, drug development and clinical applications by unlocking the power of RNA. ACD is a leader in the emerging field of molecular pathology, developing cell- and tissue-based research and diagnostic tests for personalized medicine. Based in Silicon Valley, ACD was founded and managed by experienced entrepreneurs in the life science industry. ACD's products and pharma assay services are based on its proprietary RNAscope® technology ( 1200+ publications in 6 years), the first multiplex fluorescent and chromogenic in situ hybridization platform, capable of detecting and quantifying single molecules of RNA in situ. ACD has two product lines, namely RNAscope and BaseScope(tm) in addition to a Pharma Assay Services business. The catalog includes >10,000 target probes and assay kits for single, duplex and multiplex RNA analysis. www.acdbio.com

keywords:N/A

$40.8M

Total Funding

188

Number of Employees

$36.4M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Advanced Cell Diagnostics News

2022-04-19 - Global Cancer Stem Cell Therapy Market Trend Analysis and ...

... Analysis and Major Factors Forecast Report till 2028 Trending Research Report – AVIVA BioSciences, AdnaGen, Advanced Cell Diagnostics,...

2022-04-19 - Circulating Tumor Cells Market Size And Forecast | Advanced ...

Advanced Cell Diagnostics Inc., Aviva Biosciences, Creatv Microtech Menarini Silicon Biosystems, Qiagen NV, Miltenyi Biotec, Biocept Inc.,...

2022-04-17 - Circulating Tumor Cells (CTC) Market: Latest Trends, Future ...

Advanced Cell Diagnostics, Inc. – Aviva Biosciences. – Biocept Inc. – Creatv Micro Tech, Inc. – LungLife AI, Inc.

2015-06-18 - Advanced Cell Diagnostics Raises $22M in Series C Equity Financing

Advanced Cell Diagnostics, Inc. (ACD), a Hayward, California-based leader in the field of in situ nucleic acid detection for life science research and clinical diagnostics, raised $22m in Series C equity financing. The round was led by growth equity investor Summit Partners with participation f ...

2012-11-01 - Advanced Cell Diagnostics Raises $12M in Series B Financing

Advanced Cell Diagnostics Inc. (ACD), a Hayward, CA-based life science research and clinical diagnostics company, has raised $12m in Series B financing. Backers include New Leaf Venture Partners and Morningside Ventures. The company intends to use the capital to expand its commercial efforts f ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$30M18839%N/A
#2
$24.9M18942%N/A
#3
$24.9M18942%N/A
#4
$52M19329%N/A
#5
$30.8M19320%N/A

Advanced Cell Diagnostics Funding

DateAmountRoundLead InvestorsReference
2009-09-03$5.4MUndisclosedMorningside VenturesArticle
2012-11-02$12.0MUndisclosedNew Leaf Venture Partners, Morningside VenturesArticle
2015-06-19$22.0MCSummit PartnersArticle